Myeloid sarcoma (MS) is a solid tumor of granulocytic origin with extramedullary localization. This tumor is rare in humans and animals. The diagnostic approach is heterogeneous, and the definitive diagnosis may be difficult to achieve. Primary MS has never been described as a spontaneous neoplasm in companion dogs. Two purebred and 1 mixed-breed dogs, 6- to 11-year-old, developed round cell tumors in the mediastinum, lymph nodes (LNs) and tonsils, and LNs, respectively. Granulocytic origin and exclusion of lymphoid lineage were confirmed by flow cytometry, supported by immunohistochemistry or immunocytochemistry. Pivotal to the diagnosis were positive labeling for myeloid (CD11b, CD14) and hematopoietic precursors (CD34) markers, along with negative labeling for lymphoid markers. Blood and bone marrow infiltration were not detected at initial diagnosis, excluding acute myeloid leukemia. The behavior of these tumors was aggressive, resulting in poor clinical outcomes, even when chemotherapy was attempted.

Granulocytic neoplasm suggestive of primary myeloid sarcoma in 3 dogs / A. Ubiali, V. Martini, S. Comazzi, S. Iussich, B. Miniscalco, A. Poggi, E. Morello, P. Roccabianca, B. Rütgen, C. Zamboni, F. Riondato. - In: VETERINARY PATHOLOGY. - ISSN 0300-9858. - (2024), pp. 3009858241257897.1-3009858241257897.6. [Epub ahead of print] [10.1177/03009858241257897]

Granulocytic neoplasm suggestive of primary myeloid sarcoma in 3 dogs

A. Ubiali
Primo
;
V. Martini
Secondo
;
S. Comazzi;P. Roccabianca;C. Zamboni
Penultimo
;
2024

Abstract

Myeloid sarcoma (MS) is a solid tumor of granulocytic origin with extramedullary localization. This tumor is rare in humans and animals. The diagnostic approach is heterogeneous, and the definitive diagnosis may be difficult to achieve. Primary MS has never been described as a spontaneous neoplasm in companion dogs. Two purebred and 1 mixed-breed dogs, 6- to 11-year-old, developed round cell tumors in the mediastinum, lymph nodes (LNs) and tonsils, and LNs, respectively. Granulocytic origin and exclusion of lymphoid lineage were confirmed by flow cytometry, supported by immunohistochemistry or immunocytochemistry. Pivotal to the diagnosis were positive labeling for myeloid (CD11b, CD14) and hematopoietic precursors (CD34) markers, along with negative labeling for lymphoid markers. Blood and bone marrow infiltration were not detected at initial diagnosis, excluding acute myeloid leukemia. The behavior of these tumors was aggressive, resulting in poor clinical outcomes, even when chemotherapy was attempted.
acute myeloid leukemia; bone marrow; dog; flow cytometry; histology; immunohistochemistry; lymph node; myeloid sarcoma
Settore VET/03 - Patologia Generale e Anatomia Patologica Veterinaria
Settore VET/08 - Clinica Medica Veterinaria
2024
6-giu-2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
Ubiali et al2024.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 858.41 kB
Formato Adobe PDF
858.41 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1059331
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact